Thread profile page for "Medivation" on http://www.fool.com.
This report page is a snippet summary view from a single thread "Medivation", located on the Message Board at http://www.fool.com.
This thread profile page shows the thread statistics for: Total Authors, Total Thread Posts, and Thread Activity, which are reported in a table below.
Additional thread profile information is also shown in the following ways:
Warning: These statistics are generated using 'best efforts' and can experience delays and reporting errors at times. Please note that such statistics do not constitute a thread's popularity and/or exact posting volumes at any given reporting period.
Started 2 months, 4 weeks ago (2008-07-17 18:55:00)
by missash
http://biz.yahoo.com/prnews/080717/aqth532.html?.v =11 Positive results reported in Lancet article; drug has entirely different mechanism of action than Elan's product.....Interesting. No?
Started 2 months, 4 weeks ago (2008-07-18 01:39:00)
by 11x
MDVN and ACOR are the 2 blockbuster potential drug companies I'm aware of that never seem to be discussed on this board. I may buy if they are approved by the FDA. I will buy BCSI tomorrow. I sold it at around $30 in January. I think house prices are a lot closer to bottom so I'd imagine the banks that can survive over the next few quarters will be OK. It would be nice if WFC could ...
Started 2 months, 3 weeks ago (2008-07-18 11:01:00)
by stratton6
Treatments for AD will eventually resemble combination treatment schemes for cancers. Several drugs with different mechanisms of action will be used. We just have to get to the point of finding the single drugs that work then try the combinations. Many patients, long term clinical trials, and it is very early with respect to where the trials are. JS
Size: 445 bytes
Customize:
Top contributing authors for Medivation
Name
Posts
missash
1
11x
1
stratton6
1
Related threads on "The Motley Fool Discussion Boards":